SEC Form 4 · accession 0001179110-15-002923

MOMENTA PHARMACEUTICALS INC · MNTA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP & General Counsel

Period of report

Feb 18, 2015

Accepted (ET)

Feb 19, 2015 · 3:42 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001235010

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Feb 18, 2015	A	18,862	$0.00	A	147,007	D
Common Stock	Feb 18, 2015	S	312	$11.91	D	146,695	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$13.02	Feb 18, 2015	A	37,725	A	May 18, 2015	Feb 18, 2025	Common Stock	37,725	283,157	D

F1Represents 18,862 shares of restricted common stock, $0.0001 par value per share, awarded pursuant to the Company's 2013 Stock Incentive Plan, and subject to a restricted stock agreement to be entered between the Company and Mr. Leicher. Pursuant to the restricted stock agreement, 25% of the shares of restricted Common Stock shall vest on February 18, 2016 and an additional 6.25% of the shares of restricted Common Stock shall vest at the end of each three-month period thereafter.
F2This balance of shares beneficially owned reflects 1,147 shares acquired under the employee stock plan at a purchase price of $9.10 per share on January 31, 2015.
F3Represents an option granted by the issuer pursuant to the issuer's 2013 Stock Incentive Plan. Subject to certain criteria, the shares subject to such option vest as to 6.25% of the shares at the end of each three-month period following the grant date.
F4This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2008.